Pathos AI initiates a part 1b/2a trial evaluating pocenbrodib for metastatic prostate most cancers, testing it alone or with Zytiga, Lynparza or Pluvicto.The...
On the latest 42nd Annual Miami Breast Most cancers Convention and the Educated Affected person Breast Most cancers Summit, registered nurse Patricia Jakel sat...